Barclays Maintains Overweight on SiTime, Lowers Price Target to $230
Barclays analyst Blayne Curtis maintains SiTime (NASDAQ:SITM) with a Overweight and lowers the price target from $325 to $230.
Needham Maintains Buy on SiTime, Lowers Price Target to $250
Needham analyst Quinn Bolton maintains SiTime (NASDAQ:SITM) with a Buy and lowers the price target from $300 to $250.
Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
Needham Maintains Buy on SiTime, Lowers Price Target to $300
Needham analyst Quinn Bolton maintains SiTime (NASDAQ:SITM) with a Buy and lowers the price target from $330 to $300.
Earnings Scheduled For February 2, 2022
Companies Reporting Before The Bell
• Sony Group (NYSE:SONY) is likely to report quarterly earnings at $1.57 per share on revenue of $24.59 billion.
SiTime Introduces XCalibu For Timing Industry’s Supply Chain Disruption
SiTime Corporation (NASDAQ:SITM), a market leader in MEMS timing, today introduced the SiTime® XCalibur™ active resonator. This innovative new product category solves supply chain constraints using
75 Biggest Movers From Yesterday
Gainers
Society Pass Incorporated (NASDAQ: SOPA) surged 436.7% to settle at $48.30 on Tuesday after the company priced its IPO at $9 per share.
Barclays Maintains Overweight on SiTime, Raises Price Target to $325
Barclays maintains SiTime (NASDAQ:SITM) with a Overweight and raises the price target from $245 to $325.
Credit Suisse Maintains Outperform on SiTime, Raises Price Target to $325
Credit Suisse analyst John Pitzer maintains SiTime (NASDAQ:SITM) with a Outperform and raises the price target from $225 to $325.